SCHEMBL4666568

SCHEMBL4666568

O=C1NC(CCc2ccccc2)C(O)=C1C(=O)c1nccc2ccsc12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR0B1 P51843 1/20 0.35
RAB9A P51151 1/20 0.34
PLA2G4A P47712 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
CES1 P23141 1/20 0.32
ADORA2B P29275 3/20 0.32
ADORA2A P29274 2/20 0.32
MAOB P27338 1/20 0.32
FEN1 P39748 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HDAC2 Q92769 1/20 0.32
CXCR2 P25025 1/20 0.32
GDA Q9Y2T3 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
POLB P06746 1/20 0.31
RNASEH1 O60930 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4241441 0.73 NR0B1 (0.48) NR0B1SMN1; SMN2LMNAL3MBTL1MEN1
SCHEMBL4663049 0.72 NR0B1 (0.38) NR0B1SMN1; SMN2LMNAL3MBTL1MEN1
SCHEMBL28557461 0.71 NR0B1 (0.52) NR0B1SMN1; SMN2LMNAL3MBTL1MEN1
SCHEMBL4664683 0.70 NR0B1 (0.45) NR0B1SMN1; SMN2LMNACES1L3MBTL1
SCHEMBL4664969 0.69 ABCC8 (0.37) NR0B1SMN1; SMN2LMNAMEN1ALDH1A1
SCHEMBL4664885 0.68 NR0B1 (0.43) NR0B1SMN1; SMN2LMNAMEN1ALDH1A1
SCHEMBL4664915 0.68 NPC1 (0.48) NR0B1RAB9ASMN1; SMN2LMNACES1
SCHEMBL4244260 0.68 KMT2A (0.54) NR0B1SMN1; SMN2LMNAL3MBTL1MEN1
SCHEMBL13743845 0.67 MEN1 (0.47) NR0B1RAB9ASMN1; SMN2LMNAL3MBTL1
SCHEMBL4664968 0.67 MEN1 (0.40) RAB9ASMN1; SMN2LMNAMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS GODEL THIERRY 2008-06-05 US claimed
US-20050119329-A1 Tetronic and tetramic acids HOFFMANN-LA ROCHE INC. 2005-06-02 US claimed
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS GODEL THIERRY 2008-06-05 US disclosed
US-20050119329-A1 Tetronic and tetramic acids HOFFMANN-LA ROCHE INC. 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS BACE1, PSEN1, BACE2 NR0B1 106/4885RAB9A 788/4885PLA2G4A 2775/4885
US-20050119329-A1 Tetronic and tetramic acids BACE1, PSEN1, BACE2 NR0B1 106/4885RAB9A 788/4885PLA2G4A 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.